Voyager down 7% on Genzyme exit from Parkinson’s gene therapy program – Seeking Alpha
|
Voyager down 7% on Genzyme exit from Parkinson's gene therapy program
Seeking Alpha Voyager Therapeutics (VYGR -7%) will likely end the day in the red after reporting that collaboration partner Sanofi Genzyme (SNY -0.2%) decided not to exercise its ex-U.S. rights to develop and commercialize gene therapy candidate VY-AADC for advanced … |
